Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-07

Clinical Trial Update: A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating the efficacy and safety of Supaglutide in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Supaglutide

Snippet

Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | Conditions: Type2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED